Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03407976
Title Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Utah

gastric adenocarcinoma

Advanced Solid Tumor

colorectal cancer

transitional cell carcinoma

gastroesophageal junction adenocarcinoma


Pembrolizumab + Rivoceranib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.